VBI Vaccines has entered into a research collaboration with Sanofi Pasteur to apply VBI's LPV (Lipid Particle Vaccine) formulation technology Read the full story

Sanofi has entered into a research collaboration and license agreement with Lead Pharma to discover, develop and commercialize small-molecule therapies Read the full story

Adimab announced a multi-target discovery and optimization collaboration with Sanofi Read the full story

VECT-HORUS announced the signing of a scientific collaboration agreement with SANOFI Read the full story

Evotec has entered into exclusive negotiations with Sanofi on a major multi-component strategic alliance over the next five years Read the full story

Several companies are rumored to be competing to acquire Omega Pharma, the fastest growing consumer healthcare company in the U.K. and Ireland. Read the full story

Selecta Biosciences JDRF have extended their pharma partnership and attracted Sanofi as a partner in support of their program to develop a Synthetic Vaccine Particle immunotherapy with the long-term goal to treat and potentially prevent the underlying cause of type 1 diabetes. Read the full story

Unilife and Sanofi announce a pharma partnership for $50 million. Read the full story